Showing results (651-660 of 5,659) with videos related to
Sort By:
Pageof 566
Drug Design, Development and Therapy|November 19, 2009
Indiplon in the management of insomniaMichael D Lemon, Joe D Strain, Annie M Hegg, et al.Drug Design, Development and Therapy|November 19, 2009
Management of advanced breast cancer with the epothilone B analog, ixabepiloneWilliam GradisharDrug Design, Development and Therapy|November 19, 2009
Characteristics of doripenem: a new broad-spectrum antibioticFrancisco Alvarez-Lerma, Santiago Grau, Olivia FerrándezDrug Design, Development and Therapy|November 19, 2009
T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejectionThomas H Waid, John S Thompson, Maria Siemionow, et al.Drug Design, Development and Therapy|December 10, 2014
Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutationJiao-Yu He, Cheng Li, Guo WuDrug Design, Development and Therapy|September 13, 2014
Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activityCan Chen, Ting Wang, Fengbo Wu, et al.Drug Design, Development and Therapy|January 8, 2015
Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat modelsMaowen Ba, Min Kong, Guozhao MaDrug Design, Development and Therapy|January 8, 2015
Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C: a retrospective study using the Japanese Interferon DatabaseIzumi Sato, Takuro Shimbo, Yohei Kawasaki, et al.Drug Design, Development and Therapy|January 14, 2015
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulationNobuaki Ochi, Hiromichi Yamane, Katsuyuki Hotta, et al.Drug Design, Development and Therapy|November 15, 2014
Functional analysis of tanshinone IIA that blocks the redox function of human apurinic/apyrimidinic endonuclease 1/redox factor-1Jiangdong Sui, Mengxia Li, Chengyuan Qian, et al.Pageof 566